Grange F, Couilliet D, Audhuy B, Krzisch S, Schlecht P, Guillaume J C
Service de Dermatologie, Hôpital Pasteur, Colmar.
Ann Dermatol Venereol. 1995;122(1-2):16-8.
Specific skin manifestations including skin atrophy and stripes of erythema on the extremities have been reported in patients with long-term treatment with hydroxyurea (HU).
A 60-year-old patient who had been treated with HU since 1986 for chronic myeloid leukaemia presented in March 1992 with lesions characteristic of HU-induced skin changes. Hydroxyurea was continued for two more years and the lesions worsened. Unusually encountered multiple skin keratoses developed rapidly creating a clinical picture compatible with carcinomatous transformation until the withdrawal of hydroxyurea.
The chronology and the clinical signs were in favour of implicating hydroxyurea in the development of these keratoses. The literature on the subject revealed one comparable case with actinic keratoses and multiple skin carcinomas. The interactions between hydroxyurea and the keratinocytes of the basal layer could explain different aspects of hydroxyurea-related toxidermia. The most severe manifestation could be the development of epithelial skin cancer.
长期使用羟基脲(HU)治疗的患者中曾有特定皮肤表现的报道,包括皮肤萎缩和四肢红斑条纹。
一名自1986年起接受HU治疗慢性粒细胞白血病的60岁患者,于1992年3月出现了HU诱导的皮肤变化特征性病变。羟基脲又继续使用了两年,病变恶化。异常出现的多个皮肤角化病迅速发展,形成了与癌变转化相符的临床表现,直至停用羟基脲。
时间顺序和临床体征支持羟基脲与这些角化病的发生有关。关于该主题的文献揭示了一例类似的伴有光化性角化病和多发性皮肤癌的病例。羟基脲与基底层角质形成细胞之间的相互作用可以解释羟基脲相关中毒性皮炎的不同方面。最严重的表现可能是上皮性皮肤癌的发生。